Restoration of NBD1 thermal stability is necessary and sufficient to correct ∆F508 CFTR folding and assembly.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Molecular Biology

• Publication date

  2015-01-16

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jmb.2014.07.026PMID 25083918PMCID PMC4757845
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correctors of F508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein

  2014cited by this paper
• Mechanism of the ABC transporter ATPase domains: catalytic models and the biochemical and biophysical record

  2013cited by this paper
• Discovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domain

  2013cited by this paper
• Novel pharmacological strategies to treat cystic fibrosis.

  2013cited by this paper
• Mechanism-based corrector combination restores ΔF508-CFTR folding and function

  2013cited by this paper
• Cystic fibrosis transmembrane regulator correctors and potentiators.

  2013cited by this paper
• VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1

  2013cited by this paper
• Mechanisms of CFTR Folding at the Endoplasmic Reticulum

  2012cited by this paper
• Thermal instability of ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR) channel function: protection by single suppressor mutations and inhibiting channel activity.

  2012cited by this paper
• New Model of Cystic Fibrosis Transmembrane Conductance Regulator Proposes Active Channel-like Conformation

  2012cited by this paper
• Allosteric modulation balances thermodynamic stability and restores function of ΔF508 CFTR.

  2012cited by this paper
• Requirements for efficient correction of ΔF508 CFTR revealed by analyses of evolved sequences.

  2012cited by this paper
• Correction of both NBD1 energetics and domain interface is required to restore ΔF508 CFTR folding and function.

  2012cited by this paper
• Emergent properties of proteostasis in managing cystic fibrosis.

  2011cited by this paper
• Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809

  2011cited by this paper
• Regulatory insertion removal restores maturation, stability and function of DeltaF508 CFTR.

  2010cited by this paper
• Thermal unfolding studies show the disease causing F508del mutation in CFTR thermodynamically destabilizes nucleotide‐binding domain 1

  2010cited by this paper
• The Cystic Fibrosis-causing Mutation ΔF508 Affects Multiple Steps in Cystic Fibrosis Transmembrane Conductance Regulator Biogenesis*

  2010cited by this paper
• Structures of a minimal human CFTR first nucleotide-binding domain as a monomer, head-to-tail homodimer, and pathogenic mutant.

  2010cited by this paper
• The V510D Suppressor Mutation Stabilizes ΔF508-CFTR at the Cell Surface†

  2010cited by this paper
• Integrated biophysical studies implicate partial unfolding of NBD1 of CFTR in the molecular pathogenesis of F508del cystic fibrosis

  2010cited by this paper
• Molecular models of the open and closed states of the whole human CFTR protein

  2009cited by this paper
• Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation.

  2008cited by this paper
• Multiple Membrane-Cytoplasmic Domain Contacts in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mediate Regulation of Channel Gating*

  2008cited by this paper
• CFTR function and prospects for therapy.

  2008cited by this paper
• Computational studies reveal phosphorylation-dependent changes in the unstructured R domain of CFTR.

  2008cited by this paper
• Localization studies of rare missense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) facilitate interpretation of genotype‐phenotype relationships

  2008cited by this paper
• Phenylalanine-508 mediates a cytoplasmic–membrane domain contact in the CFTR 3D structure crucial to assembly and channel function

  2008cited by this paper
• Building an understanding of cystic fibrosis on the foundation of ABC transporter structures

  2007cited by this paper
• F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive.

  2006cited by this paper
• Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.

  2006cited by this paper
• CFTR chloride channel drug discovery--inhibitors as antidiarrheals and activators for therapy of cystic fibrosis.

  2006cited by this paper
• Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules.

  2006cited by this paper
• Impact of the ΔF508 Mutation in First Nucleotide-binding Domain of Human Cystic Fibrosis Transmembrane Conductance Regulator on Domain Folding and Structure*

  2005cited by this paper
• The ΔF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR

  2005cited by this paper
• Structure of nucleotide‐binding domain 1 of the cystic fibrosis transmembrane conductance regulator

  2004cited by this paper
• Mammalian Osmolytes and S-Nitrosoglutathione Promote ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein Maturation and Function*

  2003cited by this paper
• Biosynthesis and degradation of CFTR.

  1999cited by this paper
• Cytoplasmic Loop Three of Cystic Fibrosis Transmembrane Conductance Regulator Contributes to Regulation of Chloride Channel Activity*

  1996cited by this paper
• Disease-associated Mutations in the Fourth Cytoplasmic Loop of Cystic Fibrosis Transmembrane Conductance Regulator Compromise Biosynthetic Processing and Chloride Channel Activity*

  1996cited by this paper
• Glycerol Reverses the Misfolding Phenotype of the Most Common Cystic Fibrosis Mutation (*)

  1996cited by this paper
• Identification of revertants for the cystic fibrosis delta F508 mutation using STE6-CFTR chimeras in yeast.

  1993cited by this paper
• Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites.

  1993cited by this paper
• Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive

  1992cited by this paper
• Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.

  1990cited by this paper

• Trikafta restores thermodynamic coupling between two nucleotide binding domains for potentiating CFTR activity.

  2026cites this paper
• Thermodynamic Coupling between Folding Correctors and the First of Dimerized Nucleotide Binding Domains in CFTR

  2025cites this paper
• Thermodynamic coupling between folding correctors and the first of dimerized nucleotide binding domains in CFTR

  2025cites this paper
• Thermodynamic basis for CFTR activity potentiation

  2025cites this paper
• Structure-guided combination of novel CFTR correctors to improve the function of F508del-CFTR in airway epithelial cells.

  2025cites this paper
• ATP‐Dependent Thermo‐Ring Basis for the Heat Unfolding of the First Nucleotide‐Binding Domain Isolated From Human CFTR

  2025cites this paper
• Effects of Point Mutations on the Thermal Stability of the NBD1 Domain of hCFTR

  2025cites this paper
• p.Phe508del-CFTR Trafficking: A Protein Quality Control Perspective Through UPR, UPS, and Autophagy

  2025cites this paper
• Discovery and Development of CFTR Modulators for the Treatment of Cystic Fibrosis.

  2025cites this paper
• Unraveling the Mechanism of Action, Binding Sites, and Therapeutic Advances of CFTR Modulators: A Narrative Review

  2025cites this paper
• Trikafta rescues F508del-CFTR by tightening specific phosphorylation-dependent interdomain interactions

  2024cites this paper
• ATP-dependent thermoring basis for the heat unfolding of the first nucleotide-binding domain isolated from human CFTR

  2024cites this paper
• Small molecule modulators of cystic fibrosis transmembrane conductance regulator (CFTR): Structure, classification, and mechanisms.

  2024cites this paper
• Folding correctors can restore CFTR posttranslational folding landscape by allosteric domain-domain coupling

  2023cites this paper
• Folding correctors can restore CFTR posttranslational folding landscape by allosteric domain–domain coupling

  2023cites this paper
• Adenosine triphosphate-binding cassette subfamily C members in liver hepatocellular carcinoma

  2022cites this paper
• Molecular Structures Reveal Synergistic Rescue of Δ508 CFTR by Trikafta Modulators

  2022cites this paper
• A small molecule high throughput screening platform to profile conformational properties of nascent, ribosome-bound proteins

  2022cites this paper
• New insights into structure and function of bis-phosphinic acid derivatives and implications for CFTR modulation

  2021cites this paper
• Pharmacological chaperones improve intra-domain stability and inter-domain assembly via distinct binding sites to rescue misfolded CFTR

  2021cites this paper
• Differential Effects of Oleuropein and Hydroxytyrosol on Aggregation and Stability of CFTR NBD1-ΔF508 Domain

  2021influential citation
• Nanomechanics combined with HDX reveals allosteric drug binding sites of CFTR NBD1

  2021cites this paper
• A topological switch in CFTR modulates channel activity and sensitivity to unfolding

  2021cites this paper
• CFTR corrector efficacy is associated with occupancy of distinct binding sites

  2021influential citation
• Stability Prediction for Mutations in the Cytosolic Domains of Cystic Fibrosis Transmembrane Conductance Regulator

  2021cites this paper
• Towards next generation therapies for cystic fibrosis: Folding, function and pharmacology of CFTR☆

  2020cites this paper
• Disease-relevant mutations alter amino acid co-evolution networks in the second nucleotide binding domain of CFTR

  2020cites this paper
• Targeting different binding sites in the CFTR structures allows to synergistically potentiate channel activity.

  2020cites this paper
• The ΔF508 CFTR defect: molecular mechanism of suppressor mutation V510D and the contribution of transmembrane helix unraveling

  2020cites this paper
• A Topological Switch Enables Misfolding of the Cystic Fibrosis Transmembrane Conductance Regulator

  2020cites this paper
• Membrane Protein Structure and Folding

  2020cites this paper
• A Topological Switch in the Cystic Fibrosis Transmembrane Conductance Regulator Modulates Channel Activity and Sensitivity to Disease-Causing Mutation

  2020cites this paper
• human NBD1 of CFTR in complex with nanobodies T2a and T4

  2019cites this paper
• CFTR: New insights into structure and function and implications for modulation by small molecules.

  2019cites this paper
• A defective flexible loop contributes to the processing and gating defects of the predominant cystic fibrosis‐causing mutation

  2019influential citation
• Domain-interface dynamics of CFTR revealed by stabilizing nanobodies

  2019cites this paper
• Differential Scanning Fluorimetry and Hydrogen Deuterium Exchange Mass Spectrometry to Monitor the Conformational Dynamics of NBD1 in Cystic Fibrosis.

  2018cites this paper
• Thermodynamic correction of F 508 del-CFTR 1 Ligand binding to a remote site thermodynamically corrects the F 508 del mutation in the human cystic fibrosis transmembrane conductance regulator

  2018cites this paper
• Structure-guided combination therapy to potently improve the function of mutant CFTRs

  2018cites this paper
• A novel triple combination of pharmacological chaperones improves F508del-CFTR correction

  2018cites this paper
• Structural stability of purified human CFTR is systematically improved by mutations in nucleotide binding domain 1.

  2018cites this paper
• Ligand binding to a remote site thermodynamically corrects the F508del mutation in the human cystic fibrosis transmembrane conductance regulator

  2018cites this paper
• Combining theoretical and experimental data to decipher CFTR 3D structures and functions

  2018cites this paper
• Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance

  2018cites this paper
• ΔF508-CFTR Modulator Screen Based on Cell Surface Targeting of a Chimeric Nucleotide Binding Domain 1 Reporter

  2018cites this paper
• Specific stabilization of CFTR by phosphatidylserine.

  2017cites this paper
• Direct Binding of the Corrector VX-809 to Human CFTR NBD1: Evidence of an Allosteric Coupling between the Binding Site and the NBD1:CL4 Interface

  2017cites this paper
• The implications of CFTR structural studies for cystic fibrosis drug development

  2017cites this paper
• Correcting CFTR folding defects by small‐molecule correctors to cure cystic fibrosis

  2017cites this paper
• Direct Measurement of Trafficking of the Cystic Fibrosis Transmembrane Conductance Regulator to the Cell Surface and Binding to a Chemical Chaperone.

  2017cites this paper
• Stabilization of a nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator yields insight into disease-causing mutations

  2017cites this paper
• Substitution of Yor1p NBD1 residues improves the thermal stability of Human Cystic Fibrosis Transmembrane Conductance Regulator

  2017influential citation
• Etude de la régulation du canal CFTR impliqué dans la mucoviscidose par un analogue de la GnRHet le Mg2

  2017cites this paper
• Implication du chaperome de la protéine F508del-CFTR dans son transport intracellulaire et/ou sa dégradation : rôle des lectines EDEMs et de la mannosidase du RE

  2017influential citation
• Thermal unfolding simulations of NBD1 domain variants reveal structural motifs associated with the impaired folding of F508del-CFTR.

  2016cites this paper
• Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy

  2016cites this paper
• From the endoplasmic reticulum to the plasma membrane: mechanisms of CFTR folding and trafficking

  2016cites this paper
• A Guide to Differential Scanning Calorimetry of Membrane and Soluble Proteins in Detergents.

  2016cites this paper
• The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability

  2016cites this paper
• Molecular modelling and molecular dynamics of CFTR

  2016cites this paper
• Thermal stability of purified and reconstituted CFTR in a locked open channel conformation.

  2015influential citation
• Deletion of Phenylalanine 508 in the First Nucleotide-binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator Increases Conformational Exchange and Inhibits Dimerization*♦

  2015cites this paper
• Insights into the molecular foundations of electrical excitation.

  2015cites this paper
• REMD Simulations Reveal the Dynamic Profile and Mechanism of Action of Deleterious, Rescuing, and Stabilizing Perturbations to NBD1 from CFTR

  2015cites this paper
• Controlling Allosteric Networks in Proteins.

  2013cites this paper
• Insights into the Molecular Foundations of Electrical Excitation Editorial Overview

  year unknowncites this paper